|
MX2009006706A
(es)
|
2006-12-22 |
2009-07-02 |
Astex Therapeutics Ltd |
Compuestos heterociclicos biciclicos como inhibidores del receptor del factor de crecimiento de fibroblastos.
|
|
MX2009006704A
(es)
|
2006-12-22 |
2009-06-30 |
Astex Therapeutics Ltd |
Derivados de amina triciclicos como inhibidores de proteina de tirosina cinasa.
|
|
JP5539864B2
(ja)
*
|
2007-06-12 |
2014-07-02 |
アカオゲン，インコーポレーテッド |
抗菌剤
|
|
GB0720041D0
(en)
|
2007-10-12 |
2007-11-21 |
Astex Therapeutics Ltd |
New Compounds
|
|
GB0720038D0
(en)
|
2007-10-12 |
2007-11-21 |
Astex Therapeutics Ltd |
New compounds
|
|
WO2009067493A2
(en)
*
|
2007-11-19 |
2009-05-28 |
Envivo Pharmaceuticals, Inc. |
1,3,5 tri-subtituted benzenes for treatment of alzheimer's disease and other disorders
|
|
US8217064B2
(en)
|
2007-12-20 |
2012-07-10 |
Envivo Pharmaceuticals, Inc. |
Tetrasubstituted benzenes
|
|
WO2009102893A2
(en)
|
2008-02-14 |
2009-08-20 |
Amira Pharmaceuticals, Inc. |
CYCLIC DIARYL ETHER COMPOUNDS AS ANTAGONISTS OF PROSTAGLANDIN D2 receptors
|
|
WO2009145989A2
(en)
|
2008-04-02 |
2009-12-03 |
Amira Pharmaceuticals, Inc. |
Aminoalkylphenyl antagonists of prostaglandin d2 receptors
|
|
UA103319C2
(en)
|
2008-05-06 |
2013-10-10 |
Глаксосмитклайн Ллк |
Thiazole- and oxazole-benzene sulfonamide compounds
|
|
GB0810902D0
(en)
|
2008-06-13 |
2008-07-23 |
Astex Therapeutics Ltd |
New compounds
|
|
US20110212078A1
(en)
*
|
2008-06-25 |
2011-09-01 |
Reddy Panduranga Adulla P |
Synthesis and use of heterocyclic antibacterial agents
|
|
AU2009266793B2
(en)
|
2008-07-03 |
2012-12-20 |
Brickell Biotech, Inc. |
Antagonists of prostaglandin D2 receptors
|
|
US8273900B2
(en)
|
2008-08-07 |
2012-09-25 |
Novartis Ag |
Organic compounds
|
|
US8372885B2
(en)
*
|
2008-09-17 |
2013-02-12 |
Novartis Ag |
Organic compounds and their uses
|
|
WO2010057118A2
(en)
|
2008-11-17 |
2010-05-20 |
Amira Pharmaceuticals, Inc. |
Heterocyclic antagonists of prostaglandin d2 receptors
|
|
GB0906472D0
(en)
|
2009-04-15 |
2009-05-20 |
Astex Therapeutics Ltd |
New compounds
|
|
GB0906470D0
(en)
|
2009-04-15 |
2009-05-20 |
Astex Therapeutics Ltd |
New compounds
|
|
WO2011005355A1
(en)
*
|
2009-05-07 |
2011-01-13 |
Achaogen, Inc. |
Combinations comprising a lpxc inhibitor and an antibiotic for use in the treatment of infections caused by gram-negative bacteria
|
|
FR2950057B1
(fr)
|
2009-09-17 |
2011-08-26 |
Galderma Res & Dev |
Nouveaux composes benzene-carboxylamides, leur procede de synthese et leur utilisation en medecine ainsi qu'en cosmetique
|
|
FR2950056B1
(fr)
|
2009-09-17 |
2011-08-26 |
Galderma Res & Dev |
Nouveaux composes benzene-carboxylamides, leur procede de synthese et leur utilisation en medecine ainsi qu'en cosmetique
|
|
JP2013508299A
(ja)
|
2009-10-16 |
2013-03-07 |
リブ−エックス ファーマシューティカルズ，インコーポレイテッド |
抗微生物性化合物および抗微生物性化合物の製造方法および使用方法
|
|
CN102712647B
(zh)
|
2009-10-16 |
2018-04-24 |
梅琳塔治疗公司 |
抗微生物化合物和其制备和使用方法
|
|
PH12012500734A1
(en)
|
2009-10-16 |
2012-11-26 |
Melinta Therapeutics Inc |
Antimicrobial compounds and methods of making and using the same
|
|
AU2011203649A1
(en)
|
2010-01-06 |
2012-06-14 |
Brickell Biotech, Inc. |
DP2 antagonist and uses thereof
|
|
SMT201900482T1
(it)
|
2010-04-20 |
2019-09-09 |
Fujifilm Toyama Chemical Co Ltd |
Derivato dell'acido idrossammico
|
|
US8835472B2
(en)
*
|
2010-09-02 |
2014-09-16 |
Boehringer Ingelheim International Gmbh |
Compounds, pharmaceutical compositions and uses thereof
|
|
US9738604B2
(en)
|
2010-09-03 |
2017-08-22 |
Duke University |
Ethynylbenzene derivatives
|
|
EA201390626A1
(ru)
*
|
2010-11-10 |
2013-12-30 |
Эйкеоджен, Инк. |
Производные гидроксамовой кислоты и применение указанных производных в лечении бактериальных инфекций
|
|
CN103958514B
(zh)
|
2011-04-15 |
2018-07-03 |
梅琳塔治疗公司 |
抗微生物化合物及制备和使用所述化合物的方法
|
|
US8883819B2
(en)
|
2011-09-01 |
2014-11-11 |
Irm Llc |
Bicyclic heterocycle derivatives for the treatment of pulmonary arterial hypertension
|
|
TW201315710A
(zh)
|
2011-09-12 |
2013-04-16 |
Achaogen Inc |
Ｎ－（（ｓ）－３－胺基－１－（羥胺基）－３－甲基－１－酮基丁－２－基）－４－（（（１ｒ，２ｒ）－２－（羥甲基）環丙基）丁－１，３－二炔基）苯甲醯胺之多晶型
|
|
CN102603690A
(zh)
*
|
2012-01-17 |
2012-07-25 |
凯莱英医药集团（天津）股份有限公司 |
一种一锅法制备四氢吡喃-4-甲酸及其衍生物的方法
|
|
EP3173413B1
(en)
|
2012-02-17 |
2019-05-01 |
Millennium Pharmaceuticals, Inc. |
Pyrazolopyrimidinyl inhibitors of ubiquitin-activating enzyme
|
|
WO2013170030A1
(en)
*
|
2012-05-09 |
2013-11-14 |
Achaogen, Inc. |
Antibacterial agents
|
|
EP2847168A1
(en)
|
2012-05-10 |
2015-03-18 |
Achaogen, Inc. |
Antibacterial agents
|
|
US9196844B2
(en)
*
|
2012-06-01 |
2015-11-24 |
Semiconductor Energy Laboratory Co., Ltd. |
Method of synthesizing pyrazine derivative, and light-emitting element, light-emitting device, electronic device, and lighting device
|
|
US9073921B2
(en)
|
2013-03-01 |
2015-07-07 |
Novartis Ag |
Salt forms of bicyclic heterocyclic derivatives
|
|
WO2014165075A1
(en)
|
2013-03-12 |
2014-10-09 |
Achaogen, Inc. |
Antibacterial agents
|
|
TR201911245T4
(tr)
|
2013-03-15 |
2019-08-21 |
Fujifilm Toyama Chemical Co Ltd |
Yeni hidroksamik asit türevi veya bunun tuzu.
|
|
GB201307233D0
(en)
*
|
2013-04-22 |
2013-05-29 |
Vib Vzw |
Compounds and uses thereof
|
|
BR112015032902A8
(pt)
|
2013-07-02 |
2019-12-24 |
Millennium Pharm Inc |
compostos de heteroarila, seus usos e composições farmacêuticas
|
|
US9908851B2
(en)
|
2013-08-16 |
2018-03-06 |
Duke University |
2-piperidinyl substituted N,3-dihydroxybutanamides
|
|
WO2015024010A2
(en)
|
2013-08-16 |
2015-02-19 |
Duke University |
Substituted hydroxamic acid compounds
|
|
WO2015024011A2
(en)
|
2013-08-16 |
2015-02-19 |
Duke University |
Antibacterial compounds
|
|
MX2016002975A
(es)
|
2013-09-09 |
2016-10-21 |
Melinta Therapeutics Inc |
Compuestos antimicrobianos y métodos de fabricación y utilización de los mismos.
|
|
EP3038623A4
(en)
|
2013-09-09 |
2017-04-19 |
Melinta Therapeutics, Inc. |
Antimicrobial compounds and methods of making and using the same
|
|
AR097617A1
(es)
|
2013-09-13 |
2016-04-06 |
Actelion Pharmaceuticals Ltd |
Derivados antibacterianos del 2h-indazol
|
|
TW201602065A
(zh)
*
|
2013-10-18 |
2016-01-16 |
大正製藥股份有限公司 |
異羥肟酸衍生物
|
|
JP2016210682A
(ja)
*
|
2013-10-18 |
2016-12-15 |
大正製薬株式会社 |
ヒドロキサム酸誘導体
|
|
JP2016210683A
(ja)
*
|
2013-10-18 |
2016-12-15 |
大正製薬株式会社 |
ヒドロキサム酸誘導体
|
|
JP6407288B2
(ja)
|
2013-12-19 |
2018-10-17 |
イドーシア ファーマシューティカルズ リミテッドＩｄｏｒｓｉａ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ Ｌｔｄ |
抗菌性１ｈ−インダゾール及び１ｈ−インドール誘導体
|
|
US9539305B1
(en)
|
2014-03-14 |
2017-01-10 |
Fleurir Abx Llc |
Pristinamycin compositions, LpxC compositions, their improvements, and combinations thereof
|
|
US9796686B2
(en)
*
|
2014-05-16 |
2017-10-24 |
Idorsia Pharmaceuticals Ltd |
Antibacterial quinazoline-4(3H)-one derivatives
|
|
JP6663863B2
(ja)
*
|
2014-06-12 |
2020-03-13 |
シーダーズ−サイナイ メディカル センター |
がん治療のための組成物及び方法
|
|
EP3901159A1
(en)
|
2014-07-01 |
2021-10-27 |
Millennium Pharmaceuticals, Inc. |
Heteroaryl compounds useful as inhibitors of sumo activating enzyme
|
|
MX2017002967A
(es)
|
2014-09-12 |
2017-05-30 |
Toyama Chemical Co Ltd |
Composicion farmaceutica novedosa que contiene derivado de acido hidroxamico o sal del mismo.
|
|
AU2015316400A1
(en)
|
2014-09-12 |
2017-04-06 |
Fujifilm Toyama Chemical Co., Ltd. |
Method for using novel hydroxamic acid derivative and antibacterial substance in combination
|
|
CN104341476A
(zh)
*
|
2014-10-11 |
2015-02-11 |
吉首大学 |
利奈唑胺-肌苷型多靶点抗菌化合物及其制法和用途
|
|
CN104341475A
(zh)
*
|
2014-10-11 |
2015-02-11 |
吉首大学 |
利奈唑胺-腺苷型多靶点抗菌化合物及其制法和用途
|
|
CN104231024B
(zh)
*
|
2014-10-11 |
2016-06-15 |
吉首大学 |
噁二唑-肌苷型化合物作为TyrRS抑制剂及其制法和用途
|
|
CN104262433B
(zh)
*
|
2014-10-11 |
2016-06-15 |
吉首大学 |
噁二唑-腺苷型化合物作为TyrRS抑制剂及其制法和用途
|
|
CN104327140B
(zh)
*
|
2014-10-11 |
2016-06-15 |
吉首大学 |
噁唑烷酮-腺苷型多靶点抗菌化合物及其制法和用途
|
|
CN105777464B
(zh)
*
|
2014-12-26 |
2020-09-29 |
中国科学院上海药物研究所 |
异羟肟酸衍生物及其制备方法和应用
|
|
JP6208161B2
(ja)
|
2015-02-06 |
2017-10-04 |
信越化学工業株式会社 |
非対称共役ジイン化合物の製造方法及びこれを用いたｚ，ｚ−共役ジエン化合物の製造方法
|
|
BR112017019349A2
(pt)
|
2015-03-11 |
2018-06-05 |
Melinta Therapeutics Inc |
compostos antimicrobianos e métodos de fabricação e uso dos mesmos
|
|
EP3374355A4
(en)
|
2015-11-09 |
2019-04-17 |
Forge Therapeutics, Inc. |
COMPOUNDS BASED ON PYRONE AND METHOD FOR THE TREATMENT OF BACTERIAL INFECTIONS
|
|
ES2909122T3
(es)
|
2015-11-09 |
2022-05-05 |
Forge Therapeutics Inc |
Compuestos a base de hidroxipiridinona e hidroxipirimidinona para el tratamiento de infecciones bacterianas
|
|
WO2017098440A1
(en)
*
|
2015-12-08 |
2017-06-15 |
Glaxosmithkline Intellectual Property Development Limited |
Substituted benzazinones as antibacterial compounds
|
|
CN105669750B
(zh)
*
|
2016-03-01 |
2018-04-03 |
中国医学科学院医药生物技术研究所 |
新型锌离子螯合剂及其制备和在抗革兰氏阴性菌感染中的应用
|
|
WO2017155765A1
(en)
*
|
2016-03-07 |
2017-09-14 |
Merck Sharp & Dohme Corp. |
Bicyclic aryl monobactam compounds and methods of use thereof for the treatment of bacterial infections
|
|
EP3426674A4
(en)
|
2016-03-09 |
2019-08-14 |
Blade Therapeutics, Inc. |
CYCLIC KETO AMID COMPOUNDS AS CALPAIN MODULATORS AND METHOD FOR THE PRODUCTION AND USE THEREOF
|
|
DK3445744T3
(da)
*
|
2016-04-18 |
2021-12-13 |
Vivoryon Therapeutics N V |
Hidtil ukendte inhibitorer af meprin-alfa og -beta.
|
|
AU2017257755B2
(en)
*
|
2016-04-25 |
2021-05-06 |
Duke University |
Benzoylglycine derivatives and methods of making and using same
|
|
US11098047B2
(en)
|
2016-05-06 |
2021-08-24 |
BioVersys AG |
Antimicrobials and methods of making and using same
|
|
WO2017223349A1
(en)
|
2016-06-23 |
2017-12-28 |
Achaogen, Inc. |
Antibacterial agents
|
|
WO2018009417A1
(en)
|
2016-07-05 |
2018-01-11 |
Blade Therapeutics, Inc. |
Calpain modulators and therapeutic uses thereof
|
|
KR20190063473A
(ko)
|
2016-09-28 |
2019-06-07 |
블레이드 테라퓨틱스, 인크. |
칼페인 조정자 및 그 치료학적 용도
|
|
JP7082445B2
(ja)
*
|
2016-12-23 |
2022-06-08 |
インターベット インターナショナル ベー． フェー． |
ウシ又はブタの呼吸器疾患を治療するための化合物
|
|
AU2017380070B2
(en)
*
|
2016-12-23 |
2022-03-10 |
Intervet International B.V. |
Compounds useful for treating a Mannheimia haemolytica or Histophilus somni infection
|
|
MX388196B
(es)
|
2017-04-26 |
2025-03-19 |
Basilea Pharm Int Ag |
Procesos para la preparacion de furazanobencimidazoles y formas cristalinas de estos.
|
|
WO2018208985A2
(en)
|
2017-05-10 |
2018-11-15 |
Forge Therapeutics, Inc. |
Antibacterial compounds
|
|
US20200095236A1
(en)
*
|
2017-05-10 |
2020-03-26 |
Forge Therapeutics, Inc. |
Antibacterial compounds
|
|
MY204404A
(en)
*
|
2017-07-27 |
2024-08-27 |
Biomendics Llc |
Substituted tolans for the modulation of microbial colonization
|
|
WO2019040404A1
(en)
*
|
2017-08-21 |
2019-02-28 |
Microbiotix, Inc. |
METABOLIC-STABLE METABOLIC-N-ACYLAMINOOXADIAZOLES USEFUL AS ANTIBACTERIAL AGENTS
|
|
KR102868718B1
(ko)
|
2018-02-10 |
2025-10-14 |
케이비피 바이오사이언시즈 씨오., 엘티디. |
항생제로서 작용하는 화합물
|
|
KR20200143376A
(ko)
|
2018-03-13 |
2020-12-23 |
샤이어 휴먼 지네틱 테라피즈 인크. |
혈장 칼리크레인 억제제로서의 치환된 이미다조피리딘 및 이의 용도
|
|
CN112996795B
(zh)
|
2018-09-18 |
2024-11-12 |
尼坎治疗公司 |
作为src同源-2磷酸酶抑制剂的稠合的三环衍生物
|
|
IL281614B2
(en)
|
2018-09-20 |
2024-12-01 |
Blacksmith Medicines Inc |
Antibacterial compounds
|
|
JP7189369B2
(ja)
|
2018-10-30 |
2022-12-13 |
ギリアード サイエンシーズ， インコーポレイテッド |
アルファ４β７インテグリンの阻害のための化合物
|
|
HUE070112T2
(hu)
|
2018-10-30 |
2025-05-28 |
Gilead Sciences Inc |
3-(Kinolin-8-il)-1,4-dihidropirido[3,4-d]pirimidin-2,4-dion-származékok mint alpha4beta7 integrin gátlók gyulladásos betegségek kezelésére
|
|
EP3873900B1
(en)
|
2018-10-30 |
2025-01-08 |
Gilead Sciences, Inc. |
Imidazo[1,2-a]pyridine derivatives as alpha4beta7 integrin inhibitors for the treatment of inflammatory diseases
|
|
CN112996786B
(zh)
|
2018-10-30 |
2024-08-20 |
吉利德科学公司 |
用于抑制α4β7整合素的化合物
|
|
US20220081421A1
(en)
*
|
2018-11-14 |
2022-03-17 |
Forge Therapeutics, Inc. |
Antibacterial compounds
|
|
KR20210093884A
(ko)
*
|
2018-11-21 |
2021-07-28 |
다이쇼 세이야꾸 가부시끼가이샤 |
신규 이미다졸 유도체
|
|
JP7491996B2
(ja)
|
2019-08-14 |
2024-05-28 |
ギリアード サイエンシーズ， インコーポレイテッド |
α４β７インテグリンの阻害のための化合物
|
|
WO2021055589A1
(en)
|
2019-09-18 |
2021-03-25 |
Shire Human Genetic Therapies, Inc. |
Heteroaryl plasma kallikrein inhibitors
|
|
ES2987744T3
(es)
|
2019-09-18 |
2024-11-18 |
Takeda Pharmaceuticals Co |
Inhibidores de calicreína plasmática y usos de los mismos
|
|
CN110563611B
(zh)
|
2019-09-19 |
2021-02-02 |
中国医学科学院医药生物技术研究所 |
一种异羟肟酸类衍生物及其制备方法和应用
|
|
US12441707B2
(en)
|
2019-12-30 |
2025-10-14 |
Tyra Biosciences, Inc. |
Indazole compounds
|
|
WO2021195260A1
(en)
|
2020-03-25 |
2021-09-30 |
Forge Therapeutics, Inc. |
Lpxc inhibitor and methods of making
|
|
MX2022015207A
(es)
|
2020-06-10 |
2023-02-13 |
Aligos Therapeutics Inc |
Compuestos antivirales para tratar infecciones por coronavirus, picornavirus, y norovirus.
|
|
JP7728367B2
(ja)
|
2021-06-14 |
2025-08-22 |
スコーピオン・セラピューティクス・インコーポレイテッド |
がんを処置するために使用され得る尿素誘導体
|
|
KR20240035513A
(ko)
|
2021-07-09 |
2024-03-15 |
알리고스 테라퓨틱스 인코포레이티드 |
항바이러스 화합물
|
|
WO2023011573A1
(zh)
*
|
2021-08-05 |
2023-02-09 |
浙江海正药业股份有限公司 |
芳香乙炔类衍生物及其制备方法和用途
|
|
US12065428B2
(en)
|
2021-09-17 |
2024-08-20 |
Aligos Therapeutics, Inc. |
Anti-viral compounds
|
|
JP2024536864A
(ja)
|
2021-09-28 |
2024-10-08 |
ブラックスミス メディシンズ，インク． |
Ｌｐｘｃ阻害剤およびその使用
|
|
EP4452921A1
(en)
*
|
2021-12-24 |
2024-10-30 |
Intervet International B.V. |
Process of the preparation of hydroxylamine derivatives
|
|
WO2024067813A1
(zh)
*
|
2022-09-28 |
2024-04-04 |
浙江海正药业股份有限公司 |
芳香乙炔类衍生物及其制备方法和其医药上的用途
|
|
CN115480037B
(zh)
*
|
2022-10-14 |
2023-07-18 |
青岛国泰检测科技有限公司 |
一种污水检测方法
|
|
CN115598253B
(zh)
*
|
2022-10-25 |
2025-02-21 |
无锡紫杉药业股份有限公司 |
一种多西他赛原料药中dcc和dcu残留的检测方法
|
|
AU2023393410A1
(en)
|
2022-12-16 |
2025-07-31 |
Astrazeneca Ab |
2,6,9-trisubstituted purines
|
|
CN116730870B
(zh)
|
2023-08-08 |
2023-10-13 |
中国医学科学院医药生物技术研究所 |
异羟肟酸类化合物或其可药用盐、及其用途和制备方法
|
|
CN117586278A
(zh)
*
|
2023-11-27 |
2024-02-23 |
华北制药集团先泰药业有限公司 |
一种氨苄西林钠杂质及其制备方法
|
|
WO2025155681A1
(en)
*
|
2024-01-19 |
2025-07-24 |
Corteva Agriscience Llc |
Nitrification inhibiting mixtures
|